Differential Activity of the KRAS Oncogene by Method of Activation: Implications for Signaling and Therapeutic Intervention

作者: Nathan Ihle

DOI:

关键词:

摘要: v Table of contents vii List illustrations xii tables xvi abbreviations xvii Chapter 1: Introduction 1 1.1 Ras background and function 1.1.1 The activation cycle 2 1.1.2 localization 5 1.1.3 KRAS in development 7 1.2 KRas signal transduction 8 1.3 cancer 11 1.3.1 Activating mutations viii 1.3.2 as a driver tumorigenesis 12 1.3.3 therapy 13 2: Materials methods 15 2.1 BATTLE clinical trial 2.2 Patient microarray data 2.3 Cells culture conditions 17 2.4 Preparation protein lysates reverse-phase array (RPPA) 2.5 Immunoblots immunoprecipitations 18 2.6 Viral vector construction 19 2.7 Soft agar growth assays 2.8 Molecular modeling 2.9 Screening compounds against isogenic mutant lines 20 2.10 NSCLC cell line panel 2.11 siRNA screening 2.12 Individual plasmid transfection 2.13 Spheroid formation 21 2.14 Anoikis assay 22 2.15 Cell analysis

参考文章(140)
Katherine A. Rauen, Lisa Schoyer, Frank McCormick, Angela E. Lin, Judith E. Allanson, David A. Stevenson, Karen W. Gripp, Giovanni Neri, John C. Carey, Eric Legius, Marco Tartaglia, Suzanne Schubbert, Amy E. Roberts, Bruce D. Gelb, Kevin Shannon, David H. Gutmann, Martin McMahon, Carmen Guerra, James A. Fagin, Benjamin Yu, Yoko Aoki, Benjamin G. Neel, Allan Balmain, Richard R. Drake, Garry P. Nolan, Martin Zenker, Gideon Bollag, Judith Sebolt-Leopold, Jackson B. Gibbs, Alcino J. Silva, E. Elizabeth Patton, David H. Viskochil, Mark W. Kieran, Bruce R. Korf, Randi J. Hagerman, Roger J. Packer, Teri Melese, Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back American Journal of Medical Genetics Part A. ,vol. 152, pp. 4- 24 ,(2010) , 10.1002/AJMG.A.33183
Krister Wennerberg, Kent L Rossman, Channing J Der, The Ras superfamily at a glance. Journal of Cell Science. ,vol. 118, pp. 843- 846 ,(2005) , 10.1242/JCS.01660
Matthias Drosten, Alma Dhawahir, Eleanor Y M Sum, Jelena Urosevic, Carmen G Lechuga, Luis M Esteban, Esther Castellano, Carmen Guerra, Eugenio Santos, Mariano Barbacid, Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival The EMBO Journal. ,vol. 29, pp. 1091- 1104 ,(2010) , 10.1038/EMBOJ.2010.7
N. T. Ihle, G. Powis, S. Kopetz, PI-3-Kinase inhibitors in colorectal cancer. Current Cancer Drug Targets. ,vol. 11, pp. 190- 198 ,(2011) , 10.2174/156800911794328448
Sílvia Guerrero, Agnès Figueras, Isolda Casanova, Lourdes Farré, Belen Lloveras, Gabriel Capellà, Manuel Trias, Ramon Mangues, Codon 12 and codon 13 mutations at the K-ras gene induce different soft tissue sarcoma types in nude mice The FASEB Journal. ,vol. 16, pp. 1642- 1644 ,(2002) , 10.1096/FJ.02-0050FJE
Paul M Campbell, Channing J Der, Oncogenic Ras and its role in tumor cell invasion and metastasis Seminars in Cancer Biology. ,vol. 14, pp. 105- 114 ,(2004) , 10.1016/J.SEMCANCER.2003.09.015
Emmanuelle J. Meuillet, Song Zuohe, Robert Lemos, Nathan Ihle, John Kingston, Ryan Watkins, Sylvestor A. Moses, Shuxing Zhang, Lei Du-Cuny, Roy Herbst, Jörg J. Jacoby, Li Li Zhou, Ali M. Ahad, Eugene A. Mash, D. Lynn Kirkpatrick, Garth Powis, Molecular Pharmacology and Antitumor Activity of PHT-427, a Novel Akt/Phosphatidylinositide-Dependent Protein Kinase 1 Pleckstrin Homology Domain Inhibitor Molecular Cancer Therapeutics. ,vol. 9, pp. 706- 717 ,(2010) , 10.1158/1535-7163.MCT-09-0985
Susan Wee, Zainab Jagani, Kay Xiaoqin Xiang, Alice Loo, Marion Dorsch, Yung-Mae Yao, William R. Sellers, Christoph Lengauer, Frank Stegmeier, PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers Cancer Research. ,vol. 69, pp. 4286- 4293 ,(2009) , 10.1158/0008-5472.CAN-08-4765
David A. Barbie, Pablo Tamayo, Jesse S. Boehm, So Young Kim, Susan E. Moody, Ian F. Dunn, Anna C. Schinzel, Peter Sandy, Etienne Meylan, Claudia Scholl, Stefan Fröhling, Edmond M. Chan, Martin L. Sos, Kathrin Michel, Craig Mermel, Serena J. Silver, Barbara A. Weir, Jan H. Reiling, Qing Sheng, Piyush B. Gupta, Raymond C. Wadlow, Hanh Le, Sebastian Hoersch, Ben S. Wittner, Sridhar Ramaswamy, David M. Livingston, David M. Sabatini, Matthew Meyerson, Roman K. Thomas, Eric S. Lander, Jill P. Mesirov, David E. Root, D. Gary Gilliland, Tyler Jacks, William C. Hahn, Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 Nature. ,vol. 462, pp. 108- 112 ,(2009) , 10.1038/NATURE08460
Andrew J Aguirre, Nabeel Bardeesy, Manisha Sinha, Lyle Lopez, David A Tuveson, James Horner, Mark S Redston, Ronald A DePinho, Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes & Development. ,vol. 17, pp. 3112- 3126 ,(2003) , 10.1101/GAD.1158703